UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000043139
Receipt No. R000049076
Scientific Title Prognostic significance of sarcopenia in patients treated with surgery or radiotherapy for head and neck cancer: A meta-analysis
Date of disclosure of the study information 2021/02/01
Last modified on 2022/04/16 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prognostic significance of sarcopenia in patients treated with surgery or radiotherapy for head and neck cancer: A meta-analysis
Acronym effect of sarcopenia on head and neck cancer treatment
Scientific Title Prognostic significance of sarcopenia in patients treated with surgery or radiotherapy for head and neck cancer: A meta-analysis
Scientific Title:Acronym sarcopenia and head and neck cancer
Region
Japan

Condition
Condition head and neck cancer
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate the prognostic impact of sarcopenia on head and neck cancer
Basic objectives2 Others
Basic objectives -Others effect on oncologic outcomes
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes overall survival
Key secondary outcomes disease-specific survival, disease-free survival

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria studies regarding the effect of sarcopenia on treatment outcomes in head and neck cancer
Treatment for head and neck cancer is either curative intent surgery or radiotherapy.
Key exclusion criteria studies investigating nasopharyngeal carcinoma or thyroid cancer
hazard ratios are not available
non-human studies
reviews
conference abstracts
Target sample size

Research contact person
Name of lead principal investigator
1st name takenaka
Middle name
Last name yukinori
Organization Osaka university graduate school of medicine
Division name department of otorhinolaryngology-head and neck surgery
Zip code 5650871
Address 2-2 yamadaoka, suita, osaka
TEL +81-6-6879-3951
Email ytakenaka@ent.med.osaka-u.ac.jp

Public contact
Name of contact person
1st name takenaka
Middle name
Last name yukinori
Organization Osaka university graduate school of medicine
Division name department of otorhinolaryngology-head and neck surgery
Zip code 5650871
Address 2-2 yamadaoka, suita, osaka
TEL +81-6-6879-3951
Homepage URL
Email ytakenaka@ent.med.osaka-u.ac.jp

Sponsor
Institute osaka university
Institute
Department

Funding Source
Organization self-funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization osaka university
Address 2-2 yamadaoka, suita, osaka
Tel 0662108290
Email rinri@hp-crc.med.osaka-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 02 Month 01 Day

Related information
URL releasing protocol https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259288
Publication of results Unpublished

Result
URL related to results and publications https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259288
Number of participants that the trial has enrolled 3233
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 02 Month 01 Day
Date of IRB
2021 Year 06 Month 01 Day
Anticipated trial start date
2021 Year 02 Month 01 Day
Last follow-up date
2021 Year 06 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Literature search is to be done on 2/1/2021.
Statistical analyses is to be done by 6/1/2021.

Management information
Registered date
2021 Year 01 Month 26 Day
Last modified on
2022 Year 04 Month 16 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049076